Meeting Documents
32 Outcomes
32-00 Welcome
- 32-0.1 Welcome and Practical information [.pdf]
- 32-0.2 Visa Info_STPI [.pdf]
- 32-0.3 List of Documents [.pdf]
- 32-0.4 List of Participants_10 December 2019 [.pdf]
- Group Reservation Form StopTB-UNOPS on 9-13 Dec 2019 [.pdf]
32-01 Opening 32nd Stop TB Partnership Board Meeting
32-02 Report of the Executive Director
- 32-2.1 Executive Director´s Report [.pdf]
- 32-2.2 Stop TB Partnership KPI Results 2018 updated and final [.pdf]
- 32-2.3 Stop TB Partnership KPI Results 2019 [.pdf]
32-03 Updated Global Plan 2018-2022
- 32-3.1 Final_Draft_Global_Plan_2018-2022 [.pdf]
- 32-3.2 Updated Global Plan 2018-2022_Presentation [.pdf]
32-04 Global TB Financing
- 32-4.1 TB Financing Workshop Summary Columbia University Center for SustDev_April2019 [.pdf]
- 32-4.2 TBFinancingDialogue_MeetingSummary_Final [.pdf]
- 32-4.3 TAG-StopTB Reserach Funding Trends 2005-18 [.pdf]
- 32-4.4 Global TB Financing - Bridging the financial gaps in the TB response_Presentation [.pdf]
- 32-4.5 TAG Report Tuberculosis Research Funding Trends 2005-2018 [.pdf]
32-05 Global Fund
- 32-5.1 StopTB-Global Fund Memorandum of Understanding [.pdf]
- 32-5.2 Stop TB presentation on Global Fund [.pdf]
- 32-5.3 Stop TB presentation on Global Fund [.pdf]
32-06 2020 UN Report on TB
32-07 Civil Society and Communities
- 32-7.1 StopTB CRG Work in 2019 [.pdf]
- 32-7.2 Stop TB Communities Delegation Manual [.pdf]
- 32-7.3 CS Delegations Proposal [.pdf]
- 32-7.4 CRG Board Presentation [.zip]
32-08 TB REACH 3.0
- 32-8.1_DRAFT TB REACH 3.0 Concept [.pdf]
- 32-8.2 TBREACH Paper on artificial intelligence to read chest radiographs for TB detection [.pdf]
- 32-8.3 Multi-Site Evaluation of Innovative Approaches to TB notification_TB REACH Wave 1_Plos One 2013 [.pdf]
- 32-8.4 Health extension workers improve TB finding&outcome in Ethiopia BMJ 2018 [.pdf]
- 32-8.5 Pragmatic approach to M&E interventions for improved TB detection_Methods Int Health 2014 [.pdf]
- 32-8.6 Learning Evaluation of 3 CAR Algorithms Scientifc Reports 2019 [.pdf]
- 32-8.7 Engaging the private sector in TB case detection Lancet ID 2012 [.pdf]
- 32-8.8 TB REACH 3.0_Presentation [.pdf]
32-09 Global Drug Facility
Pre read
- 32-9-1.1 STBP GDF Paediatric DRTB Initiative EB Pre-Read [.pdf]
- 32-9-1.2 TPMAT 2019 June meeting highlights [.pdf]
Resources
- 32-9.1 Global Drug Facility_Presentation [.pdf]
- 32-9-2.1 Stop TB GDF Medicines Dashboard [.pdf]
- 32-9-2.2 Indicative lead-times for planning purposes for TB products [.pdf]
- 32-9-2.3 Budgeting Prices for TB Medicines through Global Drug FacilitySTP [.pdf]
- 32-9-2.4 REUTERS_New MDR-TB treatment cost for developing countries [.pdf]
- 32-9-2.5.1 Stop TB GDF Medicines Catalog [.pdf]
- 32-9-2.5.2 Stop TB Global Drug Facility Diagnostics Catalog [.pdf]
- 32-9-2.6 GDF_Technical_Information_Note_TBLAM [.pdf]
- 32-9-2.7 GDF_Technical_Information_Note_TBLAMP [.pdf]
- 32-9-2.8 GDF_Technical_Information_Note_Xpert [.pdf]
- 32-9-2.9 Model Service Level Agreement for Xpert Surcharges v1 [.pdf]
32-10 Hosting Arrangements
32-11 Stop TB Secretariat 2020
- 32-11.1 2018 Financial Management Report [.pdf]
- 32-11.2 Narrative to the 2018 Financial Management Report [.pdf]
- 32-11.3 Operating Principle for FPF_Diagnostics_Revised [.pdf]
- 32-11.4 Operating Principle for FPF_Medicine_Revised [.pdf]
- 32-11.5 Revised FPF Process Map - Diagnostics [.pdf]
- 32-11.6 Revised FPF Process Map - Medicines [.pdf]